Method of inhibiting fibrosis with a somatostatin agonist
AssigneeSociete de Conseils de Recherches et d'Applications Scientifiques
InventorsMichael D. Culler, Philip G. Kasprzyk
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of inhibiting fibrosis in a patient. The method comprises administering a therapeutically effective amount of a somatostatin, a somatostatin agonist or a pharmaceutically acceptable salt thereof to said patent.
Claims2
A method of inhibiting fibrsois in a patient suffering from fibrosis said method comprising administering a therapeutically effective amount of somatostatin or a somatostatin agonist to said patient, provided said fibrosis is not in the kidney, in the lung, in the liver, in the skin, of the central nervous system, in bone or bone marrow, in the cardiovascular system, in an endocrine organ, or in the gastro-intestinal system, and further provided that said fibrosis is not periportal fibrosis.
Dependencies are inferred from the claim text.